Imperial Brands Share Discussion Threads

[gateside] 24/6/2022 17:08

Markets beginning to price in a slower monetary policy tightening process by the US Federal Reserve.

[marktime1231] 24/6/2022 16:58

Ahem. Or we will ignore Juul and finish the week strongly! Did I miss some good news?

[fenners66] 23/6/2022 22:49

From the BBC The US is banning the sale of all products sold by Juul, one of the country's top e-cigarette companies. The Food and Drug Administration (FDA) said it did not have enough data to be sure that marketing the firm's products was "appropriate for the protection of public health". Juul said it would challenge the move. Altria Group, which took a 35% stake in the company in 2018 for more than $12bn, has been forced to write off much of the value of its investment.

[buywell3] 22/6/2022 20:52

Better late than never, the Food and Drug Administration has announced a ban on most flavored vaping cartridges in an attempt to check e-cigarette use among teenagers and children. In a press release, the FDA said the ban covers fruit and mint flavors, leaving manufacturers only able to produce tobacco or menthol-flavored vaping cartridges. One hopes a total ban will follow

[action] 14/6/2022 18:01

Look for last year chart b4 and after interim and final divi. Happens same pattern every year. DYOR.

[cassini] 14/6/2022 17:41

Try Chesnara (CSN). It's dull, but reliable and has a hefty dividend. ~270p would be a good entry point IMO.

[1viky] 14/6/2022 15:59

RIO is good , vey volatile though. Will watch and buy around 50 if it falls. Currently in IMB and M&G. Need one good divident stock to spread out my holdings

[spud] 14/6/2022 15:32

Imperial Brands PLC 18.6% potential upside indicated by RBC Capital Markets https://www.directorstalkinterviews.com/imperial-brands-plc-18.6-potential-upside-indicated-by-rbc-capital-markets/4121068638 spud

[spud] 14/6/2022 14:54

I'm accumulating RIO, currently yielding over 10%. Although I too hold M&G. spud

[1viky] 14/6/2022 12:35

I was 100 per in IMB. Did well . But had to diversify. Missed M&G at 1.87.now in at 2.03. Looks good with buyback and dividend cover which I am hoping will go up

[tuftymatt] 14/6/2022 12:29

I would say it's a good choice 1viky as I hold M&G too. It's held up not too bad in the recent downturn and is a solid buy and hold in my book.

[1viky] 14/6/2022 12:26

Sold 45 % of IMB and bought M&G to increase dividend and spread risk. I was too much invested in IMB . Any views

[dmore2] 12/6/2022 07:17

Times up for ESG? hxxps://www.wsj.com/articles/sec-is-investigating-goldman-sachs-over-esg-funds-sources-say-11654895917?mod=e2tw

[spud] 09/6/2022 16:57

Chuck in a cannabis company and voilà!spud

[dmore2] 09/6/2022 16:19

New super cycle hTTps://www.undervalued-shares.com/reports/investment-reports/the-best-stimulant-company-in-the-world/?utm_source=twitter&utm_medium=social&utm_campaign=ru20220608

[fenners66] 09/6/2022 12:34

There is an increasing focus on making the developed world smoke free. Its going to take a long time but the market will continue to decline. There is no reason why IMB cannot continue to generate plenty of cash for years to come , but since the emphasis is certainly going to be enforcing the company's decline it would seem to me that after repaying the debt there will be ample future opportunity to buyback the equity for less in the future. So my point is the buyback is a waste of cash now. Repay debt, and therefore increase cash profit. Increase the dividends When debt is gone increase dividends some more , looks like there will even be an opportunity for some return on cash in the next few years. Then prepare for industry consolidation , buy up what is left in 5-10years and cut costs prolonging the life of the combined business. But thinking that buying their own shares which does nothing to boost declining actual profit will ultimately be pointless.

[marktime1231] 09/6/2022 12:03

Not much meat on the bones of the BAT trading statement for H1, they of course remain confidently "on track". No attempt to put a financial number on the impact of Ukraine and Russia while an exit is being negotiated, from memory IMB already booked a £200M hit. BAT remain excited about modest growth in the still-trivial novel products markets, in which they continue to invest heavily and do not expect to break even until 2025. An aggressive cost saving programme is underway presumably to counter poor performance in non-premium non-core markets, where the latter reads like price increases are offsetting the trend in global volume declines. Very like IMB, all sounds familiar. BAT dare not mention net debt other than to say it lies somewhere 2-3 x ebitda, but are happy to remind us of their £2B buyback in progress. A quick scan of both BAT and IMB asset and liability figures reminds me that the balance sheets of both these companies look horrible, astonishingly high values still attached to intangibles and frightening levels of borrowing. The difference is that this time BAT do not draw attention to what if any progress is being made to continue to reduce net debt, even though there was susbstantial reduction last year. Maybe progress has become modest while now in favour of their buyback and the ongoing investment in novel products. We will have to wait for the hard numbers. The good news read across is that BAT say they expect a full year boost from favourable exchange rates of around 5%, which pretty much accounts for their expectation of 2-4% full year revenue growth.

[spud] 09/6/2022 10:37

Probably encourage more youngsters to smoke. Since when did teenagers ever do as they were told?spud

[fenners66] 09/6/2022 10:03

As i wrote last week , if that legal approach is taken in multiple countries where does that leave the buybacks ?